NDC properties for "0.4 ML Hadlima 100 MG/ML Prefilled Syringe" (RxCUI 2640428)
About this data
The tables show NDC propoerties for 0.4 ML Hadlima 100 MG/ML Prefilled Syringe with the RxCUI 2640428
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.4 ML Hadlima 100 MG/ML Prefilled Syringe (RxCUI 2640428)
| BLA | BLA761059 |
|---|---|
| MMSL_CODE | BD39606 |
| RxCUI | 2640428 |
| SPL_SET_ID | 4774a951-3ce8-43b6-80b1-e6b23752aae6 |
| SPL_SET_ID | ccd54ad1-2fcf-4b1f-96a3-f3b2f3323383 |
| Prescribable Synonym | HADLIMA 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML Hadlima 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-bwwd 100 MG/ML Prefilled Syringe [Hadlima] |
| RxNorm Synonym | 0.4 ML Hadlima 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | Hadlima 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2640428) |
NDC Properties
NDC Item 50090670400
| NDC 9 | 50090-6704 |
|---|---|
| NDC 10 | 50090-6704-0 |
| NDC Item | 50090670400 |
| Packaging | 2 SYRINGE in 1 CARTON (50090-6704-0) / .4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 732799 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6704 |
NDC Item 78206018601
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-01 |
| NDC Item | 78206018601 |
| Packaging | 2 SYRINGE in 1 CARTON (78206-186-01) / .4 mL in 1 SYRINGE (78206-186-99) |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |
NDC Item 78206018699
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-99 |
| NDC Item | 78206018699 |
| Packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |
NDC Item 50090670400
| NDC 9 | 50090-6704 |
|---|---|
| NDC 10 | 50090-6704-0 |
| NDC Item | 50090670400 |
| Packaging | 2 SYRINGE in 1 CARTON (50090-6704-0) / .4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 732799 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6704 |
NDC Item 78206018601
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-01 |
| NDC Item | 78206018601 |
| Packaging | 2 SYRINGE in 1 CARTON (78206-186-01) / .4 mL in 1 SYRINGE (78206-186-99) |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |
NDC Item 78206018699
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-99 |
| NDC Item | 78206018699 |
| Packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |
NDC Item 50090670400
| NDC 9 | 50090-6704 |
|---|---|
| NDC 10 | 50090-6704-0 |
| NDC Item | 50090670400 |
| Packaging | 2 SYRINGE in 1 CARTON (50090-6704-0) / .4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 732799 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50090-6704 |
NDC Item 78206018601
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-01 |
| NDC Item | 78206018601 |
| Packaging | 2 SYRINGE in 1 CARTON (78206-186-01) / .4 mL in 1 SYRINGE (78206-186-99) |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |
NDC Item 78206018699
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-99 |
| NDC Item | 78206018699 |
| Packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 78206-186 |